Distinct maternal metabolites are associated with obesity and glucose-insulin axis in the first trimester of pregnancy
Open Access
- 7 April 2023
- journal article
- research article
- Published by Springer Nature in International Journal of Obesity
- Vol. 47 (7) , 529-537
Abstract
Background/Objectives: Obesity in pregnancy associates with changes in the glucose-insulin axis. We hypothesized that these changes affect the maternal metabolome already in the first trimester of human pregnancy and, thus, aimed to identify these metabolites.Patients/Methods: We performed untargeted metabolomics (HPLC-MS/MS) on maternal serum (n = 181, gestational weeks 4+0–11+6). For further analysis, we included only non-smoking women as assessed by serum cotinine levels (ELISA) (n = 111). In addition to body mass index (BMI) and leptin as measures of obesity and adiposity, we metabolically phenotyped women by their fasting glucose, C-peptide and insulin sensitivity (ISHOMAindex). To identify metabolites (outcome) associated with BMI, leptin, glucose, C-peptide and/or ISHOMA(exposures), we used a combination of univariable and multivariable regression analyses with multiple confounders and machine learning methods (Partial Least Squares Discriminant Analysis, Random Forest and Support Vector Machine). Additional statistical tests confirmed robustness of results. Furthermore, we performed network analyses (MoDentify package) to identify sets of correlating metabolites that are coordinately regulated by the exposures.Results: We detected 2449 serum features of which 277 were annotated. After stringent analysis, 15 metabolites associated with at least one exposure (BMI, leptin, glucose, C-peptide, ISHOMA). Among these, palmitoleoyl ethanolamine (POEA), an endocannabinoid-like lipid endogenously synthesized from palmitoleic acid, and N-acetyl-L-alanine were consistently associated with C-peptide in all the analyses (95% CI: 0.10–0.34; effect size: 21%;p < 0.001; 95% CI: 0.04–0.10; effect size: 7%;p < 0.001). In network analysis, most features correlating with palmitoleoyl ethanolamide and N-acetyl-L-alanine and associated with C-peptide, were amino acids or dipeptides (n = 9, 35%), followed by lipids (n = 7, 27%).Conclusions: We conclude that the metabolome of pregnant women with overweight/obesity is already altered early in pregnancy because of associated changes of C-peptide. Changes of palmitoleoyl ethanolamide concentration in pregnant women with obesity-associated hyperinsulinemia may reflect dysfunctional endocannabinoid-like signalling.Keywords
This publication has 55 references indexed in Scilit:
- Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic ApproachDiabetes, 2013
- Fetal Programming of Body Composition, Obesity, and Metabolic Function: The Role of Intrauterine Stress and Stress BiologyJournal of Nutrition and Metabolism, 2012
- MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic dataNucleic Acids Research, 2010
- Estimates of Insulin Sensitivity Using Glucose and C-Peptide From the Hyperglycemia and Adverse Pregnancy Outcome Glucose Tolerance TestDiabetes Care, 2009
- Chemical Entities of Biological Interest: an updateNucleic Acids Research, 2009
- First-Trimester Fasting Hyperglycemia and Adverse Pregnancy OutcomesDiabetes Care, 2009
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin ResistanceCell Metabolism, 2009
- GPR119, a novel G protein‐coupled receptor target for the treatment of type 2 diabetes and obesityBritish Journal of Pharmacology, 2008
- KEGG for linking genomes to life and the environmentNucleic Acids Research, 2007
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003